Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients

MeSH terms

• Adult
• Antiviral Agents / administration & dosage
• Antiviral Agents / economics
• Antiviral Agents / therapeutic use
• China
• Costs and Cost Analysis
• Cytomegalovirus Infections / diagnosis
• Cytomegalovirus Infections / epidemiology
• Cytomegalovirus Infections / prevention & control*
• Female
• Ganciclovir / administration & dosage
• Ganciclovir / economics*
• Ganciclovir / therapeutic use*
• Humans
• Infusions, Intravenous
• Kidney Transplantation / physiology*
• Male
• Postoperative Complications / epidemiology
• Postoperative Complications / virology
• Recurrence
• Retrospective Studies
• Time Factors